BioPharm International eBooksVolume 28, Issue 14 Single-use technologies including polymer film bags, tubing, filter capsules, and appropriate connectors have become widely accepted in bioprocessing of proteins and vaccines.
BioPharm International
eBooks Volume 28, Issue 14
Single-use technologies including polymer film bags, tubing, filter capsules, and appropriate connectors have become widely accepted in bioprocessing of proteins and vaccines. Recognized key benefits are elimination of cross contamination and cleaning, reduction of capital cost and environmental impact, and greater flexibility in manufacturing. Read this article and other articles in
BioPharm International
's 2015
The Future of BioprocessingeBook.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.